Mitochondrial ferritin (FtMt) is a type of ferritin that sequesters iron. Previous studies have shown that FtMt is expressed by dopaminergic neurons in the substantia nigra and that it may be involved in the pathology of Parkinson's disease. However, the functional roles of FtMt in dopaminergic neurons remain unclear. In this study, we investigated the function of FtMt in α-synuclein regulation and its antioxidant roles in dopaminergic cells using human dopaminergic neuroblastoma cells, SH-SY5Y. In physiological conditions, FtMt knockdown increased α-synuclein expression at the protein level but not at the mRNA level. By contrast, FtMt overexpression reduced α-synuclein expression at the protein level but not at the mRNA level. FtMt enhanced the iron levels in mitochondria but decreased the iron levels in the intracellular labile iron pool. We found that FeCl 2 could abolish the effects of FtMt overexpression on α-synuclein expression. Under oxidative stress conditions induced by H 2 O 2 , we found that H 2 O 2 treatment induced FtMt and α-synuclein expression at both the mRNA and protein levels in a dose-dependent manner. FtMt overexpression protected cells against oxidative stress and alleviated the enhanced α-synuclein expression induced by H 2 O 2 at the posttranscriptional level. Our results indicate that FtMt modulates α-synuclein expression at the posttranscriptional level via iron regulation in physiological conditions. FtMt expression is enhanced under oxidative stress conditions, where FtMt protects cells against the oxidative stress as well as plays an important role in maintaining α-synuclein levels.
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Introduction
Mitochondrial ferritin (FtMt) is a type of ferritin encoded by an intron-lacking gene on chromosome 5q23.1, which has a specific mitochondrial localization (Levi et al., 2001; Levi and Arosio, 2004) . The most important functions of FtMt are the sequestration of excess iron and responding to oxidative stress. FtMt shares 70% homology with heavy chain of ferritin (H-ferritin), but it has different characteristics compared with H-ferritin. For example, H-ferritin contains an ironresponsive element (IRE) in its mRNA, whereas FtMt lacks an IRE and thus it cannot be regulated by iron Levi and Arosio, 2004) . In addition, H-ferritin is distributed widely in tissues, particularly in the liver and spleen where the iron levels are high, whereas FtMt has a highly restricted tissue distribution. The expression of FtMt is very low in the liver and spleen, but relatively high in the testis, brain, heart, thymus, and kidney, which are high oxygen consumption organs Drysdale et al., 2002; Hahn et al., 2004; Yang et al., 2013) .
Previous immunohistochemical and in situ hybridization studies have shown that FtMt is expressed mainly in neurons (Santambrogio et al., 2007; Snyder et al., 2010 Snyder et al., , 2009 Wang et al., 2011) . FtMt is involved in neurodegenerative and other diseases (Gao and Chang, 2014; Yang et al., 2013) , including Alzheimer's disease (AD) (Wang et al., 2011; Wu et al., 2013; Yang et al., 2015) , restless leg syndrome (Snyder et al., 2009 ), Friedreich's ataxia (Campanella et al., 2009) , agerelated macular degeneration (He et al., 2007) , neuronal tumors (Shi et al., 2014) , and sideroblastic anemia (Cazzola et al., 2003; Cazzola and Invernizzi, 2011; Napier et al., 2005) . Previously, our group showed that FtMt is expressed in the cerebral cortex of patients with AD and that it protects neuroblastoma IMR-32 cells against H 2 O 2 -induced oxidative stress (Wang et al., 2011) . FtMt also downregulates amyloid precursor protein (APP) expression without affecting the APP mRNA levels and inhibits Aβ generation (Yang et al., 2015) . FtMt is expressed by dopaminergic neurons in the substantia nigra and its expression is higher in patients with restless leg syndrome (Snyder et al., 2009) . FtMt protects dopaminergic neurons from 6-hydroxydopamine-induced damage in a murine model of Parkinson's disease (PD) by regulating B-cell lymphoma 2 (Bcl-2), bcl-2-like protein 4 (Bax), and the caspase-3 pathway (Shi et al., 2010) . These findings suggest that FtMt might be involved in the neuroprotection of dopaminergic neurons in PD.
The pathological hallmarks of PD are the degeneration and loss of dopaminergic neurons in the substantia nigra, and the formation of cytoplasmic inclusions called Lewy bodies, which mainly comprise α-synuclein aggregates in the remaining neurons (Venda et al., 2010) . α-Synuclein is a 140-amino acid small protein, which is encoded by the SNCA gene. Studies have shown that the α-synuclein gene plays an important role in both sporadic and familial PD (Venda et al., 2010) . A53T missense point mutations and overexpression of wildtype α-synuclein accelerate iron-dependent aggregation, but they also increase free radical production in the substantia nigra, thereby leading to dopaminergic neuron death (Hsu et al., 2000; Lo Bianco et al., 2002; Ostrerova-Golts et al., 2000) . Interestingly, some recent studies have suggested that α-synuclein is modulated at the translational level by iron because an IRE is present in the 5′-untranslated region (5′-UTR) of α-synuclein mRNA (Febbraro et al., 2012; Friedlich et al., 2007) . Thus, previous studies have suggested a possible link between FtMt and α-synuclein expression. Therefore, in the present study, we investigated the function of FtMt in α-synuclein regulation and its antioxidant roles in dopaminergic cells using SH-SY5Y cells.
Materials and methods
Cell culture and transfection
Human dopaminergic neuroblastoma cells (SH-SY5Y, ATCC, Manassas, VA, USA) were grown in Dulbecco's modified Eagle medium (DMEM)/F-12 medium (Nacalai Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (Life Technologies, Carlsbad, CA, USA), 50 U/ml penicillin (Nacalai Tesque, Kyoto, Japan), and 50 μg/mL streptomycin (Nacalai Tesque, Kyoto, Japan). The growth conditions were maintained at 37°C in a humidified environment containing 95% air and 5% CO 2 . The pEGFP-N1/FtMt plasmid was established in a previous study (Wang et al., 2011) and this plasmid does not express green fluorescent protein (GFP) because EGFP is located downstream of the multiple cloning site. SH-SY5Y cells were transiently transfected with pEGFP-N1 (empty vector; Clontech Laboratories, Inc., Palo Alto, CA, USA) as a control and pEGFP-N1/FtMt using FuGENE HD transfection reagent (Promega, Madison, WI, USA) according to the manufacturer's instructions. The experiment was continued for 24 or 48 h after transfection. All of the experimental procedures employed in this study were approved by the Gene Recombination Experiment Safety Committee of Shiga University of Medical Science.
Differentiation of SH-SY5Y cells using retinoic acid and BDNF
According to the methods reported by Mastroeni et al. (Mastroeni et al., 2009) , SH-SY5Y cells were differentiated using retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). In brief, the SH-SY5Y cells employed in the present experiments (American Tissue Culture Collection, Manassas, VA) were grown in DMEM/F12 (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS (Life Technologies, Carlsbad, CA, USA) and 0.1% penicillin and streptomycin (Nacalai Tesque, Kyoto, Japan). After sub-culturing into 6-well plates (Corning Costar, Lowell, MA), cells were treated with 10 μmol/L RA (Nacalai Tesque, Kyoto, Japan) in DMEM/F12 containing 2% FBS for 3 days, followed by replenishing with fresh medium containing 10 μmol/L RA in 0.5% FBS for another 3 days. Then, the cells were treated with DMEM/F12 containing 50 ng/ml of BDNF (PeproTech, 450-02, Rocky Hill, NJ 08553, USA) and 0.5% FBS for 3 days. Undifferentiated SH-SY5Y cells cultured with DMEM/F12 supplemented with 10% FBS and 0.1% antibiotics were used as a control.
2.3. Treatment of cultured cells with H 2 O 2 , ferrous iron chloride (FeCl 2 ), and deferoxamine (DFO) Cells were seeded into six-well plates at a concentration of 1 × 10-5 cells/mL in 2 mL of complete DMEM/F-12 medium. The cells were then cultured until they reached 70%-80% confluence. H 2 O 2 (Wako Pure Chemicals Inc., Osaka, Japan), FeCl 2 (Nacalai Tesque, Kyoto, Japan), and DFO (Sigma-Aldrich, Saint Louis, MO, USA) were dissolved or diluted in ultrapure water at 50 mg/mL as stock solutions according to the manufacturers' instructions. Cells were washed twice with phosphate-buffered saline (PBS; Nacalai Tesque, Kyoto, Japan), before treatment with various concentrations of H 2 O 2 , FeCl 2 , or 50 μmol/L DFO in serum-free medium.
MTT assay
The SH-SY5Y cell suspension was dispensed into each well of a 96-well plate at a concentration of 1 × 10 4 cells/well. Cells were transfected with pEGFP-N1 and pEGFP-N1/FtMt for 24 h, as described above. The medium was replaced with serum-free medium containing 0, 50, 100, 150, 200, 300, 400, or 500 μmol/L H 2 O 2 and incubated for 24 h. Next, 10 μL of MTT solution (Nacalai Tesque, Kyoto, Japan) was added to each well and the plate was incubated at 37°C for 4 h. The medium was aspirated and the precipitated formazan was dissolved in dimethyl sulfoxide solution (Nacalai Tesque, Kyoto, Japan). The absorbance was measured at 570 nm with a TECAN infinite M200 microplate reader (TECAN, Germany).
Lactate dehydrogenase (LDH) release detection
SH-SY5Y cell suspension was dispensed into each well of a 96-well plate at a concentration of 1 × 10 4 cells/well. Cells were transfected with pEGFP-N1 and pEGFP-N1/FtMt for 24 h, as described above. The medium was replaced with serum-free medium containing 0, 50, 100, 150, 200, 300, 400 or 500 μmol/L H 2 O 2 and incubated for 24 h. Next, the release of LDH by the cells was determined using a Cytotoxicity Detection Kit PLUS (LDH) (Roche, Tokyo, Japan) according to the manufacturer's instructions. The absorbance was measured at 492 nm with a TECAN infinite M200 microplate reader (TECAN, Germany).
2.6. RNA extraction and real-time reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was purified from each sample using an RNeasy Plus Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instructions. The cDNA was reverse-transcribed from 5 μg of total RNA using a Superscript III First-Strand Synthesis System with Oligo dT (Life Technologies). Taqman Gene expression assays (FtMt, Hs00893202_s1; SNCA, Hs00240906_m1; β-actin, 4326315E) and Taqman Fast Advanced Master Mix (Life Technologies, Carlsbad, CA, USA) were employed for RT-PCR. RT-PCR was performed as described previously (Wang et al., 2011; Yang et al., 2015) and the data obtained were analyzed using Light Cycler software (Roche Diagnostics, Tokyo, Japan). (Biontex, Planegg, Germany) according to the manufacturer's instructions. Cells were incubated for 72 h before harvesting, followed by Western blotting or RT-PCR.
Intracellular labile iron pool (LIP) measurement
SH-SY5Y cells (10,000 cells/well) were seeded onto a black 96-well plate and treated as described above. Intracellular LIP was detected using a Calcein AM Assay Kit (Trevigen, Gaithersbug, Germany) according to the manufacturer's instructions (Connor et al., 2015) . Fluorescence was measured at an excitation wavelength of 490 nm and an emission wavelength of 520 nm using a TECAN infinite M200 microplate reader (TECAN, Germany).
Determination of iron in mitochondria
Mitochondria were isolated from SH-SY5Y cells treated as described above using a Mitochondria Isolation Kit for Cultured Cells (Thermo Scientific, Rockford, IL, USA) according to the manufacturer's instructions. Next, iron was determined in the mitochondria using an Iron Colorimetric Assay Kit (BioVision, Milpitas, USA) according to the manufacturer's instructions. The absorbance was measured at 593 nm using a TECAN infinite M200 microplate reader (TECAN, Germany).
Protein extraction and Western blotting
Cells were washed twice with ice cold PBS before lysing with lysis buffer (10 mmol/L HEPES-Na, pH 7.4, 150 mmol/L NaCl, 1 mmol/L EDTA, 1% Nonidet P-40) containing a protease inhibitor cocktail (Roche, Nutley, NJ, USA). The cell lysates were incubated on ice for 30 min and centrifuged at 10,000 × g for 25 min at 4°C, where the supernatants were collected as whole cell lysates. The protein concentration was determined using the bicinchoninic acid assay (Pierce Biotechnology, Rockford, IL, USA) according to the manufacturer's instructions. Western blotting was performed as described previously (Wang et al., 2011) . Equal amounts of protein (10 μg) were denatured at 95°C for 5 min, applied to the lanes in precast 15% polyacrylamide gels (Wako Pure Chemicals Inc.), electrophoresed, and transferred to a nitrocellulose membrane (BIO-RAD, Germany). The membranes were blocked with 5% skim milk in Tris-buffered saline containing 1% Tween 20 (TBST) at room temperature for 30 min and incubated overnight at 4°C with the following primary antibodies: anti-FtMt established by our laboratory, which we have confirmed could not recognize H-ferritin (1:10,000) (Yang et al., 2015) ; anti-α-synuclein (1:10,000, ab27766, Abcam, Cambridge, MA, USA), anti-β-synuclein (1:5000, sc-136452, Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-COX4 (1:5000, PM063, Medical & Biological Laboratories Co Ltd., Nagoya, Japan); anti-TH (1:1000, MAB318, Millipore, Temecula, CA, USA); and anti-β-actin (1:10,000, sc-47778, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Membranes were washed three times with TBST (i.e., for 15 min each time) and then incubated at room temperature for 1 h with the following secondary antibodies: goat anti-mouse IgG or goat anti-rabbit IgG labeled with horseradish peroxidase (1:10,000, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). After three further washes with TBST, the membrane was reacted with enhanced chemiluminescent substrate (SuperSignal West Pico, Thermo Scientific, Rockford, IL, USA) and detected using an ImageQuant LAS 4000 mini system (GE Healthcare Life Science, Milwaukee, WI, USA).
Immunocytochemistry
Cells were seeded onto poly-L-lysine (Sigma-Aldrich, Saint Louis, MO, USA) coated coverslips in 12-well plates and transfected with pEGFP-N1/FtMt. At 24 h after transfection, the cells were incubated for 30 min with 100 nmol/L MitoTracker (Life Technologies), which is a mitochondrial marker. The cells were then washed briefly with PBS, fixed in 4% ice-cold paraformaldehyde (Nacalai Tesque, Kyoto, Japan) for 10 min at 4°C, and permeabilized with 0.1% Triton X-100 (Nacalai Tesque, Kyoto, Japan) in PBS (PBST) for 10 min at room temperature. Cells were blocked with 4% bovine serum albumin (Sigma-Aldrich, Saint Louis, MO, USA) in PBST, before incubating overnight at 4°C with anti-FtMt (1:500). The cells were then washed with PBST three times, each for 5 min, and incubated with donkey anti-rabbit IgG Alex Fluor 488 (1:500, Life Technologies, Carlsbad, CA, USA) for 2 h at room temperature. Next, the cells were washed three times with PBST, each for 5 min, and then incubated with DAPI (Life Technologies) for 5 min at room temperature. After washing the cells three times with PBST, each for 5 min, they were observed using a confocal laser scanning biological microscope (Olympus, Tokyo, Japan).
Statistical analysis
All of the experiments were replicated more than three times and each sample was analyzed in triplicate. Values represent the mean ± standard error of the mean (SEM). The results were analyzed using a two-tailed unpaired Student's t-test, one-way analysis of variance (ANOVA) with Bonferroni's post-hoc test, or two-way ANOVA to compare groups. A p-value b0.05 was considered to indicate a significant difference.
Results
Comparison of TH and FtMt expression between SH-SY5Y cells with and without differentiation
To explore the role of FtMt in dopaminergic neuron-like cells, SH-SY5Y cells were differentiated with RA and BDNF. The morphology of cells after differentiation is presented to be more neuron-like with outgrowth and network of neurites compared with undifferentiated cells (Fig. 1a) . Both differentiated and undifferentiated SH-SH5Y cells expressed TH (tyrosine hydroxylase), a rate-limiting enzyme of dopamine synthesis, although it was found to be expressed much higher in differentiated cells (Fig. 1b, c) . Compared with undifferentiated cells, FtMt expression also increased after differentiation (Fig. 1d, e) . However, the transfection efficiency of the differentiated SH-SY5Y cells was very low (about 1%). Therefore, we used SH-SY5Y cells without RA/BDNF treatment for further studies.
FtMt suppresses α-synuclein expression without affecting α-synuclein mRNA levels
To investigate the effects of FtMt on the α-synuclein levels, we transfected the empty vector and FtMt plasmid into cells for 48 h, before measuring α-synuclein expression by Western blotting and the α-synuclein mRNA levels by RT-PCR. The average transfection efficiency is 13.8% (S.D = 0.016) (Supplementary Fig. 1a ). After FtMt transfection, overexpressed FtMt was localized in the mitochondria (Fig. 2g) , and α-synuclein expression was inhibited by 35% compared with the empty vector-transfected control group (Fig. 2a, b) , but there was no effect on the expression of β-synuclein, which is highly homologous to α-synuclein ( Supplementary Fig. 1b, c) . However, the overexpression of FtMt did not modulate the α-synuclein mRNA levels (Fig. 2c) . To further confirm that FtMt inhibits α-synuclein expression, we transfected the negative control medium GC duplex and FtMt siRNA separately into cells for 72 h. As shown in Fig. 2d , FtMt was successfully knocked down after siRNA transfection. By contrast, α-synuclein expression increased by approximately 90% compared with the control levels after FtMt knockdown (Fig. 2d, e) . However, FtMt knockdown did not affect the α-synuclein mRNA levels (Fig. 2f) , thereby suggesting that FtMt regulates α-synuclein expression at the posttranscriptional level.
FtMt overexpression abolishes the iron-induced upregulation of α-synuclein
To explore the mechanism that allows FtMt to affect α-synuclein expression, SH-SY5Y cells were treated with FeCl 2 at concentrations of 0, 25, 50, 100, 500, or 1000 μmol/L. The α-synuclein protein expression level was increased by FeCl 2 treatment at concentrations ≥100 μmol/L (Fig. 3a, b) , whereas the α-synuclein mRNA level was unchanged after exposure to FeCl 2 (Fig. 3c) . Thus, 100 μmol/L FeCl 2 was selected for use in the next experiment. We transfected the empty vector or FtMt plasmid into cells for 24 h, before treatment with 100 μmol/L FeCl 2 or 50 μmol/L DFO (an iron chelator) for another 24 h. In a previous study (H. H. Cho et al., 2010) , DFO concentrations above 100 μmol/L were found to be toxic to SH-SY5Y cells. Thus, we selected a DFO concentration of 50 μmol/L as a negative control for cell exposure. DFO at 50 μmol/L inhibited α-synuclein expression by approximately 40% (Fig. 3d , e) compared with the levels in the vector control. FtMt overexpression also suppressed α-synuclein expression, in agreement with the results shown in Fig. 2a-b . The inhibitory effect of FtMt overexpression was abolished by the addition of 100 μmol/L FeCl 2 , thereby indicating that FtMt probably suppresses α-synuclein expression via iron regulation. However, the α-synuclein expression levels of FtMttransfected cells after exposure to 50 μmol/L DFO were not further decreased compared with those of FtMt-transfected cells without exposure to 50 μmol/L DFO or no-FtMt-transfected cells after exposure to DFO ( Supplementary Fig. 2b, c) . Moreover, there were no significant changes of COX4 protein levels, even after FeCl 2 treatment or transfection of FtMt (Supplementary Fig. 2a ). The level of COX4 also reflected the level of β-actin in the present study, indicating that both COX4 and β-actin can be used interchangeably as the loading control. To examine the effects of FtMt on α-synuclein aggregations, we exposed the Western blot membranes for a long time (Supplementary Fig. 3 ). The long-time exposure revealed several bands of high molecular weights, which exhibited no clear tendency (Supplementary Fig. 3 ).
FtMt sequesters iron in mitochondria and decreases the intracellular LIP levels
To further investigate how FtMt modulates α-synuclein expression via iron regulation, we examined how the iron distribution in cells was affected by FtMt. First, we determined the intracellular LIP level, where we found that FtMt overexpression decreased the LIP level by approximately 50% (Fig. 4a) . Similar to the overexpression of FtMt, DFO also decreased the LIP level. FeCl 2 increased the LIP level but also abolished the reduction in the LIP level induced by FtMt overexpression (Fig. 4a) . By contrast, FtMt knockdown increased the LIP level by 125% (Fig. 4b) , which suggests that FtMt plays a role in maintaining the LIP level. Second, we determined the iron levels in mitochondria and found that they increased after the overexpression of FtMt (Fig. 4c) .
FeCl 2 increased the mitochondrial iron levels in both FtMt overexpression cells and no-FtMt overexpression cells. DFO inhibited FeCl 2 -induced elevation in mitochondrial iron level (Supplementary Fig. 5a ). Moreover, the mitochondrial iron levels in FtMt overexpression cells were increased more than those in no-FtMt overexpression cells after exposure to FeCl 2 (Fig. 4c) . However, DFO did not affect the iron levels in mitochondria, whereas the iron levels in mitochondria were decreased by approximately 45% after FtMt knockdown (Fig. 4d) . Therefore, these results indicate that FtMt leads to iron transfer from LIP in the cytosol into mitochondria.
FtMt rescues SH-SY5Y cells from H 2 O 2 -induced reactive oxygen species (ROS)
To investigate whether FtMt might play a neuroprotective role in SH-SY5Y cells under H 2 O 2 -induced oxidative stress, cells were transfected with either the empty vector or FtMt plasmid for 24 h, before treatment with 0, 50, 100, 150, 200, 300, 400, or 500 μmol/L H 2 O 2 for another 24 h. The cell viability decreased in a dose-dependent manner after exposure to H 2 O 2 . FtMt reduced the damage caused by exposure to H 2 O 2 from 50 to 400 μmol/L (Fig. 5a ), but there was no difference between the FtMt overexpression cells and no-FtMt overexpression cells after exposure to 500 μmol/L H 2 O 2 (Fig. 5a ). Although Fig. 2 . Effects of mitochondrial ferritin (FtMt) overexpression or suppression on α-synuclein expression at the protein and mRNA levels. a-c SH-SY5Y cells were transfected with empty vector or FtMt plasmids for 48 h. Cell lysates were subjected to Western blotting. Extracted RNA was subjected to RT-PCR. a Overexpression of FtMt decreased α-synuclein expression at the protein level. b Quantitative analysis of α-synuclein expression after normalization against β-actin. c mRNA level of α-synuclein after normalization against β-actin mRNA. The results show that FtMt overexpression did not affect the α-synuclein mRNA level. d-e SH-SY5Y cells were transfected with negative control medium GC duplex or FtMt small interfering RNA for 72 h. Cell lysates were subjected to Western blotting. Extracted RNA was subjected to RT-PCR. d FtMt knockdown upregulated α-synuclein expression at the protein level. e Quantitative analysis of α-synuclein after normalization against β-actin. f mRNA level of α-synuclein after normalization against β-actin mRNA. The results show that FtMt knockdown did not affect the α-synuclein mRNA level. Values are relative to 100% for the control group. Data were analyzed using the two-tailed unpaired Student's t-test and they represent the mean ± SEM (n = 4). NS: no significant difference, *p b 0.05, versus control. g SH-SY5Y cells were transfected with pEGFP-N1/FtMt for 48 h. Cells were subjected to immunocytochemistry. Exogenous FtMt overexpressed by plasmids was localized in the mitochondria.
both DFO and FtMt have the function of chelating iron, DFO could not protect cells from H 2 O 2 treatment ( Supplementary Fig. 4 ). In addition, we examined the LDH release level as an index of cytotoxicity after exposure to various concentrations of H 2 O 2 and found that FtMt inhibited the LDH release caused by H 2 O 2 at concentrations of 50 to 400 μmol/L (Fig. 5b) , whereas FtMt failed to inhibit LDH release after exposure to 500 μmol/L H 2 O 2 .
FtMt and α-synuclein are increased by H 2 O 2 in SH-SY5Y cells
To observe the reactions of FtMt and α-synuclein to H 2 O 2 -induced ROS, we measured the α-synuclein and FtMt expression levels after exposure to H 2 O 2 for 24 h. FtMt protein expression was increased in a dose-dependent manner by H 2 O 2 , where it reached a plateau at 100 μmol/L and decreased at H 2 O 2 concentrations over 200 μmol/L Fig. 3 . Effects of FeCl 2 treatment on α-synuclein expression with or without mitochondrial ferritin (FtMt) overexpression. a-c SH-SY5Y cells were treated with various concentrations of FeCl 2 for 24 h. a FeCl 2 increased α-synuclein protein expression in a dose-dependent manner. b Quantitative analysis of α-synuclein after normalization against β-actin. c mRNA level of α-synuclein after normalization against β-actin mRNA. The results show that the α-synuclein mRNA level was not affected by the treatment with FeCl 2 . Values are relative to 100% for the notreatment group. Data were analyzed by one-way analysis of variance with Bonferroni's post-hoc test to compare the groups and they represent the mean ± SEM (n = 3) after normalization against β-actin mRNA. d The inhibitory effect of FtMt overexpression was abolished by adding FeCl 2 . Cells were transfected with the empty vector or FtMt plasmid for 24 h, before treatment with 100 μmol/L FeCl 2 or 50 μmol/L deferoxamine (DFO) for a further 24 h. α-Synuclein Protein expression was increased by FeCl 2 and decreased by DFO treatment or FtMt overexpression. e Quantitative analysis of α-synuclein after normalization against β-actin. All values are relative to 100% for the control group. Data were analyzed by one-way analysis of variance with Bonferroni's post-hoc test to compare groups and they represent the mean ± SEM (n = 3). *p b 0.05,**p b 0.01 versus control, #p b 0.05, ##p b 0.01 versus 100 μmol/L FeCl 2 treatment in the FtMt-transfected group. NS: no significant difference. (Fig. 6a, b) . In close agreement with the FtMt protein expression level, FtMt mRNA expression was increased in a dose-dependent manner by H 2 O 2 and it also reached a plateau at 100 μmol/L (Fig. 6c) . Similarly, α-synuclein protein expression increased in a dose-dependent manner after exposure to H 2 O 2 , where it reached a plateau at 80 μmol/L and decreased at H 2 O 2 concentrations over 150 μmol/L (Fig. 6d, e) . The α-synuclein mRNA level increased after exposure to H 2 O 2 and reached a plateau at 80 μmol/L (Fig. 6f) . In addition, we found that H 2 O 2 could decrease the levels of intracellular labile iron pool (Supplementary Fig.  5b ).
FtMt partially rescues H 2 O 2 -induced α-synuclein expression but not the mRNA level
To investigate whether FtMt could inhibit the α-synuclein expression induced by H 2 O 2 -induced ROS, cells were transfected with the either empty vector or FtMt plasmid for 24 h, before treatment with or without 80 μmol/L H 2 O 2 for another 24 h. As shown in Fig. 6a and d, the endogenous FtMt and α-synuclein expression levels increased after exposure to H 2 O 2 compared with the empty vector-transfected cells without exposure to H 2 O 2 (Fig. 7a) . Overexpression of FtMt alleviated the α-synuclein expression induced by H 2 O 2 , but the α-synuclein expression level in FtMt-transfected cells exposed to H 2 O 2 was higher than that observed in the empty vector-transfected cells without exposure to H 2 O 2 (Fig. 7a, b) . However, the α-synuclein mRNA levels in FtMt-transfected cells exposed to H 2 O 2 and empty vector-transfected cells exposed to H 2 O 2 did not differ, although both were higher than that in cells without exposure to H 2 O 2 (Fig. 7c) .
Discussion
SH-SY5Y cells both with and without differentiation were widely used as a model of dopaminergic cells (Xie et al., 2010) . Thus, we compared the expression of FtMt in both cell types. To differentiate SHSY5Ycells, we used RA and BDNF. Because RA-induced differentiated cells showed cholinergic phenotype (Xie et al., 2010) , while cells Values are relative to 100% for the negative control group. Data were analyzed using the two-tailed unpaired Student's t-test and they represent the mean ± SEM (n = 3). *p b 0.05, versus negative control. differentiated by the combination of RA and BDNF displayed dopaminergic properties (Mastroeni et al., 2009) . Both differentiated and undifferentiated SH-SH5Y cells expressed TH, with the expression level being much higher in differentiated cells. Interestingly, FtMt expression was also increased after differentiation, suggesting that FtMt plays some roles in dopaminergic cells. However, the transfection efficiency of the differentiated SH-SY5Y cells was very low (about 1%). Therefore, we used SH-SY5Y cells without RA/BDNF treatment for further studies.
In this study, we first demonstrate that FtMt can repress the expression of α-synuclein. This result indicates that FtMt plays an important role in maintaining α-synuclein levels. FtMt could not alter β-synuclein expression which is highly homologous to α-synuclein, suggesting that the inhibition of FtMt by α-synuclein is specific. Interestingly, these alterations in α-synuclein expression occurred at the protein levels but not at the mRNA levels, thereby suggesting that FtMt regulates α-synuclein expression in a posttranscriptional stage.
Recent studies have shown that an IRE comprising 46 nucleotides is present in the 5′-UTR of α-synuclein mRNA (Febbraro et al., 2012; Friedlich et al., 2007) . IRE in 5′-UTR of α-synuclein mRNA is highly similar to the IRE present in ferritin mRNA 5′-UTR and APP mRNA 5′-UTR (Friedlich et al., 2007; Rogers et al., 2002) . IRE in 5′-UTR of an mRNA of iron-associated protein can be regulated by IRP/IRE system. The binding of IRP to IRE can be enhanced by decreasing intracellular iron, post which it will repress the translation of these iron-associated proteins' mRNA but not affect their mRNA levels (H.-H. Cho et al., 2010; Rogers and Munro, 1987; Rogers et al., 2002) . Conversely, under the conditions of high intracellular iron, IRP is released from IRE to increase the translational efficiency (Clarke et al., 2006; Ke et al., 1998) . However, in IRP/ IRE system of iron-associated protein (e.g., TfR) which present IRE in 3′-UTR of mRNA, binding of IRP to IRE will enhance mRNA stability, resulting in increasing mRNA levels, and more protein will be translated (Müllner and Kühn, 1988; Rouault, 2006) . Since IRE exist in α-synuclein mRNA, it is reasonable to speculate that α-synuclein could be regulated by iron. Therefore, we investigated the effect of iron on α-synuclein and found that it could increase α-synuclein protein expression but not alter its mRNA levels, suggesting that iron regulates α-synuclein at a posttranscriptional stage. Furthermore, we transfected an empty vector and FtMt plasmids into cells, before treatment with FeCl 2. Consequently, we found that FeCl 2 abolished the inhibitory effects of FtMt overexpression on α-synuclein expression. In addition, DFO suppressed α-synuclein expression in the same manner as FtMt. These results suggest that FtMt affects α-synuclein expression via iron regulation.
FtMt is particularly highly localized in mitochondria, but it is first synthesized as a 30-KDa precursor in the cytoplasm, which is imported into mitochondria via a leading sequence, where it is proteolytically cleaved to the 22-KDa mature FtMt . Given that endogenous FtMt is particularly highly expressed in mitochondria, we determined whether exogenous FtMt was expressed by plasmids localized in mitochondria, and we found that exogenous FtMt was expressed by plasmids localized in mitochondria-like endogenous FtMt, which agreed with our previous study using HEK293 cells (Yang et al., 2015) .
In mammals, iron in cells is mainly bound to various components such as ferritin, heme, hemoglobin, and enzymes (Prus and Fibach, 2008) . LIP, which exists primarily in the cytosol, is dynamic (Breuer et al., 1996) and it is considered to be the crossroads for cellular iron traffic (Prus and Fibach, 2008) . LIP comprises free iron ions bound to low affinity ligands, which connect various compartments in cells (Baker et al., 1992; Epsztejn et al., 1997; Ponka et al., 1984; Rothman et al., 1992) , and changes in its levels can affect the activity of iron-responsive protein (Epsztejn et al., 1997) . The LIP level is regulated to meet the cell's requirements for iron (Prus and Fibach, 2008) . In this study, we found that FtMt could decrease the LIP level, which suggests that FtMt negatively regulates LIP levels and that it is involved in the metabolism of iron.
FtMt is a type of iron storage protein that sequestrates iron, as mentioned above; therefore, we determined the iron levels in mitochondria after FtMt overexpression and knockdown, where the results showed that the iron levels in mitochondria were elevated after FtMt overexpression as well as exposure to FeCl 2 . By contrast, the iron levels in mitochondria were decreased after FtMt knockdown. These results suggest that FtMt leads to iron transfer into mitochondria from LIP in the cytoplasm. Interestingly, DFO was not effective in altering the iron levels in mitochondria. Thus, it is still unclear why DFO could decrease the LIP level but not the iron levels in mitochondria, although previous studies suggest that it may be due to the poor permeability of mitochondrial to DFO (Hoyes and Porter, 1993; Ihnat et al., 2000) . We also statistically analyzed iron levels in intracellular LIP and mitochondria between DFO treatment and FtMt overexpression. The iron levels in intracellular LIP could be decreased by DFO treatment or FtMt overexpression, and there was no statistical difference between their levels. In contrast, the iron level in the mitochondria was increased by FtMt overexpression, while it remained unchanged by the DFO treatment. These results suggest that α-synuclein expression is regulated by iron level intracellular LIP but not mitochondrial iron level. In addition, the reduction of α-synuclein protein by FtMt overexpression is probably due to the reduction of iron level intracellular LIP but not alteration in mitochondrial iron level. In summary, it seems that FtMt downregulates α-synuclein expression at a post-transcription level via iron regulation.
It is widely accepted that ROS occur in the substantia nigra of PD patients where they lead to dopaminergic neuron death. Dopaminergic neurons are the main locations of dopamine generation and they contain substantial amounts of tyrosine hydroxylase. In addition, dopamine is an unstable molecule and it may be vulnerable to auto-oxidation (Dias et al., 2013; Muñoz et al., 2012) . Dopaminergic neurons release reactive species during the metabolism of dopamine, including oxygen radicals and H 2 O 2 (Sulzer, 2007) . Given that ROS are the main trigger for the loss of dopaminergic neurons, we determined whether FtMt could protect dopaminergic cells from H 2 O 2 -induced ROS. Interestingly, FtMt reduced the cell damage induced by H 2 O 2 , which agreed with the results of our previous study using neuroblastoma IMR-32 cells (Wang et al., 2011) . To confirm the protective effect on dopaminergic cells, we measured the LDH release levels as an index of cytotoxic effects. Fig. 6 . H 2 O 2 increased mitochondrial ferritin (FtMt) and α-synuclein expression at both the protein and mRNA levels. SH-SY5Y cells were treated with H 2 O 2 for 24 h. Whole cell lysates were subjected to Western blotting and the extracted total RNA was subjected to RT-PCR. a H 2 O 2 induced FtMt expression. b Quantitative analysis of FtMt in a after normalization against β-actin. c FtMt mRNA level after normalization against β-actin mRNA. These results show that FtMt expression was induced at both the protein and mRNA levels by H 2 O 2 in a dosedependent manner up to 150 μmol/L. d H 2 O 2 induced α-synuclein expression. e Quantitative analysis of α-synuclein in d after normalization against β-actin. f mRNA level of α-synuclein after normalization against β-actin mRNA. The results show that α-synuclein expression was induced at both the protein and mRNA levels by H 2 O 2 in a dose-dependent manner up to 120 μmol/L. All values are relative to 100% for the untreated group. Data were analyzed by one-way analysis of variance with Bonferroni's post-hoc test to compare groups and they represent the mean ± SEM (n = 3). *p b 0.05, **p b 0.01, ***p b 0.001 versus group without H 2 O 2 treatment. We showed that FtMt reduces the LDH release induced by H 2 O 2 , which indicates that FtMt has a protective role against H 2 O 2 -induced oxidative stress in dopaminergic cells.
In order to investigate the relationship between α-synuclein and FtMt under H 2 O 2 -induced oxidative stress, we examined the expression of α-synuclein and FtMt after exposure to H 2 O 2 . As we reported previous (Wang et al., 2011) , FtMt expression was induced at a concentration of 300 μmol/L H 2 O 2 in human IMR-32 neuroblastoma cells. However, in SH-SY5Y dopaminergic cells, FtMt protein expression was increased in a dose-dependent manner by H 2 O 2 and it reached a plateau at 100 μmol/L H 2 O 2 . This suggests that dopaminergic cells are more sensitive to H 2 O 2 -induced ROS-mediated cell damage. FtMt mRNA was also elevated by H 2 O 2 in a dose-dependent manner, so we suggests that H 2 O 2 induced FtMt expression at a pre-transcriptional level. Similar to FtMt, both the protein and mRNA levels of α-synuclein were increased by H 2 O 2 , thereby suggesting that H 2 O 2 induced α-synuclein expression at a pre-transcriptional level. ROS occur in the substantia nigra of PD patients, so we investigated the effects of FtMt on α-synuclein under H 2 O 2 -induced oxidative stress condition, which showed that FtMt overexpression could partially inhibit the enhanced α-synuclein expression induced by H 2 O 2 , whereas it was not reversed at the protein level. In addition, FtMt failed to prevent the increase in the α-synuclein mRNA level induced by H 2 O 2 . These results suggest that FtMt inhibits α-synuclein expression at a posttranscriptional stage under H 2 O 2 -induced oxidative stress conditions.
We must acknowledge that this study had several limitations. First, the neuropathological hallmark of PD was found in the dopaminergic neurons of the substantia nigra, so it would be more suitable to use primary dopaminergic neurons rather than dopaminergic neuroblastoma cells. However, we found that the dopaminergic neuroblastoma cell line was convenient for genetic manipulation and treatments. In particular, we needed to extract protein and mRNA from a large number of cells in order to measure the protein and mRNA expression levels, and the dopaminergic neuroblastoma cell line proliferates readily to yield a large number of cells. Therefore, we selected the dopaminergic neuroblastoma cell line, SH-SY5Y, as the model cell line for use in this study, but we plan to employ primary dopaminergic neurons in our future research. Furthermore, we did not investigate the relationship between α-synuclein and FtMt in animals. Recently, a novel strain of FtMt-null mice was established (Maccarinelli et al., 2014) and it may be possible to determine the effects of FtMt on α-synuclein using transgenic mice. Finally, we did not determine changes in the FtMt levels in the substantia nigra of PD specimens.
Conclusions
In this study, we found FtMt expression was increased in differentiated SH-SY5Y cells and investigated the effects of FtMt on α-synuclein under physiological and H 2 O 2 -induced oxidative stress conditions in undifferentiated SH-SY5Y cells. Our results showed that FtMt leads to iron transfer into mitochondria from LIP in the cytoplasm. According to the mechanism of IRP/IRE system clarified by previous reports of other groups, reduction of iron levels in intracellular LIP caused enhancement of binding IRP to IRE, leading to inhibition of mRNA translation into protein. Consequently, α-synuclein was decreased by FtMt. Under pathological conditions, H 2 O 2 increased the expression of α-synuclein through increasing mRNA levels. However, this phenomenon can be partially inhibited by FtMt via inhibiting α-synuclein mRNA translation. Furthermore, FtMt overexpression rescued SH-SY5Y cells from H 2 O 2 -induced oxidative stress. Overall, these results suggest that FtMt has neuroprotective effects against H 2 O 2 -induced oxidative stress as well as maintaining α-synuclein expression levels at the posttranscriptional level via iron regulation (Fig. 8) .
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.expneurol.2017.02.001.
